Nov 2, 2023

DMC opens new lab in Research Triangle Park, NC – New 9,500 Square Foot R&D Facility

Morrisville, NC, 2 November 2023 – DMC Biotechnologies is announcing a new 9,500 square foot (880 square meter) metabolic engineering and fermentation facility in the Research Triangle Park (RTP) area of North Carolina, to support a team of scientists advancing DMC products and active collaborations.

The research and development lab employs a team of metabolic engineers, precision fermentation specialists, automation experts, and analytical support. The facility is home to DMC’s workflows in strain and metabolic engineering, high throughput testing, as well as bench and pilot scale fermentation. The RTP facility compliments DMC’s Boulder facility, which manages the company’s downstream separation and purification development activities.

DMC’s precision fermentation bioprocesses, which leverage its proprietary Dynamic Metabolic Control™ technology, enables the production of low carbon and economical chemicals. Improving the sustainability of chemicals is critical to mitigating future climate change.

Kenny Erdoes, DMC CEO said, “We are proud to announce the opening of our new laboratory in North Carolina. This new facility will support a growing team and enable us to bring online additional capabilities and streamline existing workflows to accelerate the development of new sustainable chemical solutions.”

North Carolina currently ranks among the top three U.S. states for bioscience employment and is a leader in vaccine research and manufacturing.

DMC media contact:
Kathryn Sheridan
Sustainability Consult
[email protected]
[email protected]

About DMC
DMC is a US bio-based chemical company that makes sustainably produced bio-based chemicals using
microbial fermentation. DMC’s proprietary Made to Scale™ technology platform makes fermentation
more standardized, robust, and predictable, transforming how the world makes chemicals.
DMC’s technology platform addresses the key barriers that have plagued the biotech industry for
decades including standardization, robustness, and predictability across scale. Addressing these
challenges translates to a dramatic reduction in the time to market and the investment needed to bring
products to commercialization.

For more information, visit: www.dmcbio.com

Other NEWS

DMC Appoints Kenny Erdoes as COO

DMC Appoints Kenny Erdoes as COO

17 May 2022 – DMC Biotechnologies has appointed Kenny Erdoes as Chief Operating Officer (COO), effective immediately. Kenny has more than 20 years of experience in process engineering, project development and manufacturing operations. Kenny Erdoes is a chemical...

read more